Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Protilo DM
- Development stage
- Unknown
- Lead developer
- Prisure Medicare
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Protilo DM is a specialized nutritional supplement developed by Prisure Medicare, an Indian pharmaceutical company. Formulated as a sugar-free protein powder, it is specifically designed for the dietary management of individuals with diabetes mellitus (indicated by the 'DM' suffix). The product provides a balanced profile of essential proteins, vitamins, and minerals to support metabolic health and address nutritional gaps in patients requiring a low-glycemic index diet. It is marketed as a chocolate-flavored powder intended for oral administration after reconstitution.
- Brand names
- Protilo DMProtilo DM Powder
- Other names
- Protilo DM Powder (Chocolate)
Beyond the preview
Go deeper on Protilo DM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Protilo DM.